Treatment of REM Behavior Disorder
AssigneeVanda Pharmaceuticals Inc.
InventorMihael Polymeropoulos
Life of this patent
Estimating the term…
Abstract
Embodiments of the invention relate generally to the treatment of sleep-related disorders. One aspect of the invention includes a method of treating a patient suffering from rapid eye movement (REM) behavior disorder (RBD) comprising: administering to the patient an effective dose of tasimelteon before bedtime.
Claims19
A method of treating a patient suffering from rapid eye movement (REM) behavior disorder (RBD) comprising:
- administering to the patient an effective dose of tasimelteon before bedtime.
In a method of administering tasimelteon to a patient, the improvement comprising:
- selecting as said patient an individual suffering from rapid eye movement (REM) behavior disorder (RBD).
A method of treating a patient suffering from rapid eye movement (REM) behavior disorder (RBD) in whom treatment with a benzodiazepine was ineffective, the method comprising:
- administering to the patient an effective dose of tasimelteon before bedtime.
Dependencies are inferred from the claim text.